Document
IPR2014-01043, No. 1054 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
Cite Document
IPR2014-01043, No. 1054 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1027 Exhibit - Expunged (P.T.A.B. Jun. 26, 2014)
Cite Document
IPR2014-01043, No. 1027 Exhibit - Expunged (P.T.A.B. Jun. 26, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1017 Exhibit - Expunged (P.T.A.B. Jun. 26, 2014)
Cite Document
IPR2014-01043, No. 1017 Exhibit - Expunged (P.T.A.B. Jun. 26, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1041 Exhibit - Expunged (P.T.A.B. Jun. 26, 2014)
Cite Document
IPR2014-01043, No. 1041 Exhibit - Expunged (P.T.A.B. Jun. 26, 2014)
+ More Snippets
Document
IPR2014-01043, No. 2011 Exhibit - Senju Exhibit 2011 (P.T.A.B. Nov. 20, 2014)
Cite Document
IPR2014-01043, No. 2011 Exhibit - Senju Exhibit 2011 (P.T.A.B. Nov. 20, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1018-2 Exhibit - METRICS 1018 Flach, Allan, Topical Nonsteroidal Antiinflammatory Drugs for Ophthalmic Uses (P.T.A.B. Aug. 20, 2014)
Cite Document
IPR2014-01043, No. 1018-2 Exhibit - METRICS 1018 Flach, Allan, Topical Nonsteroidal Antiinflammatory Drugs for Ophthalmic Uses (P.T.A.B. Aug. 20, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1028-2 Exhibit - METRICS 1028 Yanni et al, US Patent No 5475034 (P.T.A.B. Aug. 20, 2014)
Cite Document
IPR2014-01043, No. 1028-2 Exhibit - METRICS 1028 Yanni et al, US Patent No 5475034 (P.T.A.B. Aug. 20, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1015-2 Exhibit - METRICS 1015 US Patent Application No 13687242, 21114, Notice of Allowance (P.T.A.B. Aug. 20, 2014)
Cite Document
IPR2014-01043, No. 1015-2 Exhibit - METRICS 1015 US Patent Application No 13687242, 21114, Notice of Allowance (P.T.A.B. Aug. 20, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1021 Exhibit - Expunged (P.T.A.B. Jun. 26, 2014)
Cite Document
IPR2014-01043, No. 1021 Exhibit - Expunged (P.T.A.B. Jun. 26, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1037-2 Exhibit - METRICS 1037 FDA approved ALREX loteprednol etabonate ophthalmic suspension (P.T.A.B. Aug. 20, 2014)
Cite Document
IPR2014-01043, No. 1037-2 Exhibit - METRICS 1037 FDA approved ALREX loteprednol etabonate ophthalmic suspension (P.T.A.B. Aug. 20, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1056 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
Cite Document
IPR2014-01043, No. 1056 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1080 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
Cite Document
IPR2014-01043, No. 1080 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1086 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
Cite Document
IPR2014-01043, No. 1086 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1084 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
Cite Document
IPR2014-01043, No. 1084 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
+ More Snippets
Document
IPR2014-01043, No. 1066 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
Cite Document
IPR2014-01043, No. 1066 Exhibit - Expunged (P.T.A.B. Jul. 29, 2014)
+ More Snippets